Literature DB >> 19442424

Disseminated intravascular coagulation in obstetric disorders and its acute haematological management.

Jecko Thachil1, Cheng-Hock Toh.   

Abstract

As activation of the coagulation pathway is a physiological response to injury, the development of disseminated intravascular coagulation (DIC) is a warning signal to the clinician that the primary pathological disease state is decompensating. In pregnancy, DIC can occur in several settings, which include emergencies such as placental abruption and amniotic fluid embolism as well as complications such as pre-eclampsia. Whilst the acuteness of the event and the proportionality in the coagulant and fibrinolytic responses may vary between these different conditions, a common theme for pregnancy-associated DIC is the pivotal role played by the placenta. Removal of the placenta is the linchpin to treatment in most cases but appropriate blood product support is also key to management. This is necessary because DIC itself can have pathological consequences that translate clinically into a worse prognosis for affected patients. This article will describe how pregnancy-associated DIC can be diagnosed promptly and how treatment should be managed strategically. It also discusses the latest developments in our understanding of haemostatic mechanisms within the placenta and how these may have relevance to new diagnostic approaches as well as novel therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442424     DOI: 10.1016/j.blre.2009.04.002

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  20 in total

1.  Identification of the primary outcomes that result from deficient spiral arterial modification in pregnant mice.

Authors:  B Anne Croy; Suzanne D Burke; Valerie F Barrette; Jianhong Zhang; Kota Hatta; Graeme N Smith; Juares Bianco; Aureo T Yamada; Michael A Adams
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

Review 2.  [Anesthesiological approach to postpartum hemorrhage].

Authors:  J Knapp; S Hofer; H Lier
Journal:  Anaesthesist       Date:  2016-03       Impact factor: 1.041

3.  Maternal and pregnancy-related death: causes and frequencies in an autopsy study population.

Authors:  Claas Buschmann; Martina Schmidbauer; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2012-12-29       Impact factor: 2.007

Review 4.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

5.  Blood Component Utilization for Disseminated Intravascular Coagulation (DIC) Cases with Respect to Underlying Condition.

Authors:  Snehalata C Gupte; Abhay G Jhaveri
Journal:  Indian J Hematol Blood Transfus       Date:  2015-04-25       Impact factor: 0.900

Review 6.  Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline.

Authors:  Heiko Lier; Christian von Heymann; Wolfgang Korte; Dietmar Schlembach
Journal:  Transfus Med Hemother       Date:  2017-11-15       Impact factor: 3.747

Review 7.  Thrombocytopenic syndromes in pregnancy.

Authors:  Matthew Yan; Ann K Malinowski; Nadine Shehata
Journal:  Obstet Med       Date:  2015-09-21

Review 8.  Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum.

Authors:  Arturo J Martí-Carvajal; Gabriella Comunián-Carrasco; Guiomar E Peña-Martí
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

9.  A retrospective analysis of transfusion management for obstetric hemorrhage in a Japanese obstetric center.

Authors:  Shigetaka Matsunaga; Hiroyuki Seki; Yoshihisa Ono; Hideyoshi Matsumura; Yoshihiko Murayama; Yasushi Takai; Masahiro Saito; Satoru Takeda; Hiroo Maeda
Journal:  ISRN Obstet Gynecol       Date:  2012-02-06

10.  Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.

Authors:  Ali Alhousseini; Roberto Romero; Neta Benshalom-Tirosh; Dereje Gudicha; Percy Pacora; Dan Tirosh; Doron Kabiri; Lami Yeo; Jecko Thachil; Chaur-Dong Hsu; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.